tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Advertisement

4D Molecular Therapeutics (FDMT) Ownership - Who Owns 4D Molecular Therapeutics?

Compare
450 Followers

4D Molecular Therapeutics (FDMT) Ownership Overview

12.46%14.56%1.76%12.29%58.93%
12.46% Insiders
1.76% Other Institutional Investors
12.29% ETFs
58.93% Public Companies and
Individual Investors
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 28.61% of the company’s stock is owned by Institutional Investors, 12.46% is owned by Insiders, and 58.93% is owned by Public Companies and Individual Investors.
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 16.32% of the company’s stock is owned by Institutional Investors, 12.46% is owned by Insiders, and 12.29% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,563,211Institution9.77%44,901,996
4,563,211Insider9.77%44,901,996
2,183,562Institution4.68%21,486,250
2,033,575Institution4.35%20,010,378
1,732,092Institution3.71%17,043,785
1,515,682Institution3.25%14,914,311
1,278,171Institution2.74%12,577,203
1,059,153Insider2.27%10,422,066
836,834Institution1.79%8,234,447
455,449Institution0.98%4,481,618

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,033,575Institution4.35%20,010,378
1,515,682Institution3.25%14,914,311
836,834Institution1.79%8,234,447
455,449Institution0.98%4,481,618
355,377Institution0.76%3,496,910
327,192Institution0.70%3,219,569
264,671Institution0.57%2,604,363
158,842Institution0.34%1,563,005
155,024Institution0.33%1,525,436
130,435Institution0.28%1,283,480

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,504,225Institution3.22%13,071,715
959,849Institution2.06%9,444,914
360,396Institution0.77%3,131,841
343,359Institution0.74%3,378,653
310,600Institution0.67%3,093,576
310,600Institution0.67%3,093,576
310,600Institution0.67%3,093,576
264,541Institution0.57%2,603,083
191,590Institution0.41%1,664,917
168,975Institution0.36%1,704,958

FAQ

Who Owns 4D Molecular Therapeutics (FDMT)?
According to the latest TipRanks data, approximately 1.76% of the company's stock is held by institutional investors, 12.46% is held by insiders, and 58.93% is held by retail investors.
    What percentage of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.76% of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors.
      What percentage of 4D Molecular Therapeutics (FDMT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 58.93% of 4D Molecular Therapeutics (FDMT) stock is held by retail investors.
        Who owns the most shares of 4D Molecular Therapeutics (FDMT)?
        Peter Kolchinsky owns the most shares of 4D Molecular Therapeutics (FDMT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis